Ashton Thomas Private Wealth, LLC Spring Works Therapeutics, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.83 Trillion
- Q2 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 345 shares of SWTX stock, worth $12,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345Holding current value
$12,275% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$233 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$200 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$132 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$128 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$122 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.22B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...